Back to Agenda
Walking the Talk: What Happens When Clinical Trialists Join Clinical Trials?
Session Chair(s)
Jane Myles
VP, Programs and Initiatives, Digital Trials and Research Alliance, United States
In this forum we share experiences as volunteers in Phase 3 COVID-19 vaccine trials. Few of us enroll in trials, even though our work is designing, executing, and analyzing clinical trials. This is a way to learn through our participation.
Learning Objective : Discuss stories of participating in a COVID-19 vaccine trial as a healthy volunteer; Evaluate insights on the patient experience in the trial, and the key takeaways as a clinical trialist that are made clear by participation; Identify potential options for a different patient experience in future trials that leverage technology and other patient-centric trial solutions.
Speaker(s)
Kelly Johnston McKee, MS
Head of Innovative Patient Recruitment, Evinova, An Astrazeneca Company, United States
Panelist
Angela Radcliffe
Head, Data Governance and Stewardship, Bristol-Myers Squibb Company , United States
Panelist
Craig Serra, MBA, MS
Head of Commercial Solutions and Partnerships, Flatiron Health, United States
Panelist
Have an account?